Literature DB >> 26510853

The Nutritional Intake of Patients with Organic Acidaemias on Enteral Tube Feeding: Can We Do Better?

Anne Daly1, S Evans2, A Gerrard2, S Santra2, S Vijay2, A MacDonald2.   

Abstract

BACKGROUND: Detailed nutritional intake data on children with organic acidaemias (OA) (propionic acidaemia (PA), vitamin B12 nonresponsive methylmalonic acidaemia (MMA) and isovaleric acidaemia (IVA)) remains unreported. Aim and subjects: A review of the longitudinal nutritional intake of 14 children with organic acidaemias (PA n = 8; MMA n = 5; IVA n = 1) dependent on enteral tube feeding (≥90% of energy requirements) from a single treatment centre.
METHODS: Nutritional intake (energy, protein, precursor-free L-amino acids, vitamins and minerals), anthropometry and nutritional biochemistry data were collated from diagnosis to current age.
RESULTS: The median energy intake was only 72% (63-137) of the estimated average DH (1991) requirement (EAR), decreasing significantly by 40% between 6 months and 5 years (p < 0.05). Total protein intake met WHO/FAO/UNU (2007) safe intake levels with median (range) precursor-free L-amino acids providing 21% (14-28) of total protein intake. Median mineral intake for sodium was 57% (20-97%), potassium 64% (27-125%) and magnesium 72% (22-116%) and was consistently < RNI for all age points. Fibre median intake was 4 g/day (0-11 g), and fluid intake provided 80% (60-100%) of the requirements for age. Linear growth was poor, and children were overweight for their height (1-10 years: z score median weight +0.6, height -1.2). Nutritional markers consistently indicated that plasma valine concentrations were < target reference ranges in PA and MMA. Iron deficiency anaemia was common in MMA/PA, and in PA, 50% of plasma zinc concentrations were < reference range.
CONCLUSION: In MMA/PA, energy intake decreases over time, weight gain accelerates, but linear height is poor. There are many nutrient deficiencies which may affect short- and long-term outcome of patients with organic acidaemias. The quality of long-term diet in these conditions deserves more attention.

Entities:  

Keywords:  Amino acids organic acidaemias; Energy; Isovaleric acidaemia; Methylmalonic acidaemia; Propionic acidaemia; Protein

Year:  2015        PMID: 26510853      PMCID: PMC5059221          DOI: 10.1007/8904_2015_443

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  24 in total

1.  Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations.

Authors:  Natalie S Hauser; Irini Manoli; Jennifer C Graf; Jennifer Sloan; Charles P Venditti
Journal:  Am J Clin Nutr       Date:  2010-11-03       Impact factor: 7.045

2.  Propionic acidemia revisited: a workshop report.

Authors:  J O Sass; M Hofmann; D Skladal; E Mayatepek; B Schwahn; W Sperl
Journal:  Clin Pediatr (Phila)       Date:  2004 Nov-Dec       Impact factor: 1.168

3.  Increased urinary metabolite excretion during fasting in disorders of propionate metabolism.

Authors:  G N Thompson; R A Chalmers
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

4.  Clinical outcome and long-term management of 17 patients with propionic acidaemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier; P Parvy; J Bardet; P Kamoun; J M Saudubray
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

5.  Resting energy expenditure in disorders of propionate metabolism.

Authors:  F Feillet; O A Bodamer; M A Dixon; S Sequeira; J V Leonard
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

6.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

8.  The worldwide magnitude of protein-energy malnutrition: an overview from the WHO Global Database on Child Growth.

Authors:  M de Onís; C Monteiro; J Akré; G Glugston
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

9.  Protein and amino acid requirements in human nutrition.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2007

10.  Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria.

Authors:  L De Raeve; L De Meirleir; J Ramet; Y Vandenplas; E Gerlo
Journal:  J Pediatr       Date:  1994-03       Impact factor: 4.406

View more
  3 in total

1.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

Review 2.  Nutrient Intake and Nutritional Status in Adult Patients with Inherited Metabolic Diseases Treated with Low-Protein Diets: A Review on Urea Cycle Disorders and Branched Chain Organic Acidemias.

Authors:  Francesco Francini-Pesenti; Giorgia Gugelmo; Livia Lenzini; Nicola Vitturi
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

3.  Dietary practices in propionic acidemia: A European survey.

Authors:  A Daly; A Pinto; S Evans; M F Almeida; M Assoun; A Belanger-Quintana; S M Bernabei; S Bollhalder; D Cassiman; H Champion; H Chan; J Dalmau; F de Boer; C de Laet; A de Meyer; A Desloovere; A Dianin; M Dixon; K Dokoupil; S Dubois; F Eyskens; A Faria; I Fasan; E Favre; F Feillet; A Fekete; G Gallo; C Gingell; J Gribben; K Kaalund Hansen; N M Ter Horst; C Jankowski; R Janssen-Regelink; I Jones; C Jouault; G E Kahrs; I L Kok; A Kowalik; C Laguerre; S Le Verge; R Lilje; C Maddalon; D Mayr; U Meyer; A Micciche; U Och; M Robert; J C Rocha; H Rogozinski; C Rohde; K Ross; I Saruggia; A Schlune; K Singleton; E Sjoqvist; R Skeath; L H Stolen; A Terry; C Timmer; L Tomlinson; A Tooke; K Vande Kerckhove; E van Dam; T van den Hurk; L van der Ploeg; M van Driessche; M van Rijn; A van Wegberg; C Vasconcelos; H Vestergaard; I Vitoria; D Webster; F J White; L White; H Zweers; A MacDonald
Journal:  Mol Genet Metab Rep       Date:  2017-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.